Search research articles
Contact Us
Filters
Showing results (101-110 of 144) with videos related to
Page
of 15
Sort By:
BMC Cancer
|
April 3, 2019
Systemic and tumor-directed therapy for oligometastatic prostate cancer: study protocol for a phase II trial for veterans with de novo oligometastatic disease
Neil R Parikh, Claudia Huiza, Jill S Patel, et al.
The Lancet. Oncology
|
July 11, 2021
Nomograms to predict outcomes after <sup>177</sup>Lu-PSMA therapy in men with metastatic castration-resistant prostate cancer: an international, multicentre, retrospective study
Andrei Gafita, Jeremie Calais, Tristan R Grogan, et al.
Prostate Cancer and Prostatic Diseases
|
July 11, 2020
The intraprostatic immune environment after stereotactic body radiotherapy is dominated by myeloid cells
Nicholas G Nickols, Ekambaram Ganapathy, Christine Nguyen, et al.
Clinical Genitourinary Cancer
|
June 8, 2019
Germline Genetic Testing in Advanced Prostate Cancer; Practices and Barriers: Survey Results from the Germline Genetics Working Group of the Prostate Cancer Clinical Trials Consortium
Channing J Paller, Emmanuel S Antonarakis, Tomasz M Beer, et al.
European Urology Oncology
|
February 19, 2021
Identifying the Best Candidates for Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography as the Primary Staging Approach Among Men with High-risk Prostate Cancer and Negative Conventional Imaging
Ting Martin Ma, Andrei Gafita, David Shabsovich, et al.
JAMA Oncology
|
March 29, 2019
Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical Trial
Wolfgang P Fendler, Jeremie Calais, Matthias Eiber, et al.
European Urology Oncology
|
June 20, 2025
Pooled Analysis of the SOLAR and SATURN Clinical Trials Comparing Progression of Synchronous Versus Metachronous Prostate-specific Membrane Antigen-defined Oligometastatic Prostate Cancer Following Systemic and Tumor-directed Therapy
Jesus E Juarez Casillas, John Nikitas, Matthew B Rettig, et al.
European Urology
|
September 20, 2024
Testosterone Recovery Following Androgen Suppression and Prostate Radiotherapy (TRANSPORT): A Pooled Analysis of Five Randomized Trials from the Meta-Analysis of Randomized Trials in Cancer of the Prostate (MARCAP) Consortium
Wee Loon Ong, Tahmineh Romero, Soumyajit Roy, et al.
JCO Precision Oncology
|
July 16, 2024
Transcriptomic Profiling of Primary Prostate Cancers and Nonlocalized Disease on Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography: A Multicenter Retrospective Study
John Nikitas, Kritika Subramanian, Nimrod Barashi Gozal, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 14, 2021
Refining the definition of biochemical failure in the era of stereotactic body radiation therapy for prostate cancer: The Phoenix definition and beyond
Ting Martin Ma, Soumyajit Roy, Xue Wu, et al.
Page
of 15
Search research articles
Search
Showing results (101-110 of 144) with videos related to
Sort By:
Page
of 15
BMC Cancer
|
April 3, 2019
Systemic and tumor-directed therapy for oligometastatic prostate cancer: study protocol for a phase II trial for veterans with de novo oligometastatic disease
Neil R Parikh, Claudia Huiza, Jill S Patel, et al.
The Lancet. Oncology
|
July 11, 2021
Nomograms to predict outcomes after <sup>177</sup>Lu-PSMA therapy in men with metastatic castration-resistant prostate cancer: an international, multicentre, retrospective study
Andrei Gafita, Jeremie Calais, Tristan R Grogan, et al.
Prostate Cancer and Prostatic Diseases
|
July 11, 2020
The intraprostatic immune environment after stereotactic body radiotherapy is dominated by myeloid cells
Nicholas G Nickols, Ekambaram Ganapathy, Christine Nguyen, et al.
Clinical Genitourinary Cancer
|
June 8, 2019
Germline Genetic Testing in Advanced Prostate Cancer; Practices and Barriers: Survey Results from the Germline Genetics Working Group of the Prostate Cancer Clinical Trials Consortium
Channing J Paller, Emmanuel S Antonarakis, Tomasz M Beer, et al.
European Urology Oncology
|
February 19, 2021
Identifying the Best Candidates for Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography as the Primary Staging Approach Among Men with High-risk Prostate Cancer and Negative Conventional Imaging
Ting Martin Ma, Andrei Gafita, David Shabsovich, et al.
JAMA Oncology
|
March 29, 2019
Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical Trial
Wolfgang P Fendler, Jeremie Calais, Matthias Eiber, et al.
European Urology Oncology
|
June 20, 2025
Pooled Analysis of the SOLAR and SATURN Clinical Trials Comparing Progression of Synchronous Versus Metachronous Prostate-specific Membrane Antigen-defined Oligometastatic Prostate Cancer Following Systemic and Tumor-directed Therapy
Jesus E Juarez Casillas, John Nikitas, Matthew B Rettig, et al.
European Urology
|
September 20, 2024
Testosterone Recovery Following Androgen Suppression and Prostate Radiotherapy (TRANSPORT): A Pooled Analysis of Five Randomized Trials from the Meta-Analysis of Randomized Trials in Cancer of the Prostate (MARCAP) Consortium
Wee Loon Ong, Tahmineh Romero, Soumyajit Roy, et al.
JCO Precision Oncology
|
July 16, 2024
Transcriptomic Profiling of Primary Prostate Cancers and Nonlocalized Disease on Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography: A Multicenter Retrospective Study
John Nikitas, Kritika Subramanian, Nimrod Barashi Gozal, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 14, 2021
Refining the definition of biochemical failure in the era of stereotactic body radiation therapy for prostate cancer: The Phoenix definition and beyond
Ting Martin Ma, Soumyajit Roy, Xue Wu, et al.
Page
of 15